Patients on shorter regimen also had fewer bleeding events at 1 year regardless of background OAC treatment
Patients with high bleeding risk (HBR) who undergo dual antiplatelet therapy (DAPT) for 1 month post-percutaneous coronary intervention (PCI) have similar rates of all-cause death or myocardial infarction (MI) to patients receiving 3 months of DAPT, a new analysis shows.